The former head of Equinor Ventures joins bp ventures at a time of transition at the fund.
Month: January 2023
How to diversify the CVC industry
We asked corporate investors about why lack of diversity persists and what it might take to change it.
Daily Deal Round Up: January 10th, 2023
CVS Health led a $375m round for Monogram Health while its CVS Health Ventures unit led Carbon Health’s $100m series D.
Is 2023 the boom year for CVC?
Several new corporate venture units have launched in the past few weeks, showing that big business is still committed to startup investing.
Daily Deal Round Up: January 9th, 2023
Novo and Mass General Brigham participated in Amolyt’s $138m series C round while Munters contributed to Qvantum’s $45m series B.
What next for healthcare CVC in 2023?
What’s going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.
The Big Deal: Metagenomi shows that gene therapies continue to pull in big funding
The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.
Daily Deal Round Up: January 6th, 2023
Kelun Pharmaceutical spinoff Kelun Biotech raised $581m in a round also featuring Merck & Co, while KreditBee hiked its MUFG-backed series D to $180m.
“Talk to me, drones” – Meet the company designing the AI wingman
With a fresh cash injection from Raytheon’s RTX Ventures, EpiSci is creating autonomous software to enhance warfighters’ capabilities.
Nath and Gupta leap forward in Jump Capital
After both serving three years as Jump Capital’s vice-presidents, Saaya Nath and Tarun Gupta have been promoted to the firm’s partners.
Daily Deal Round Up: January 5, 2023
Novo co-led a second tranche that lifted Metagenomi’s series B round to $275m while crypto payment technology provider Wyre is shutting after a $1.5bn acquisition fell through.
New VCs rely increasingly on corporate support
Corporations are playing a bigger role in supporting new entrants to the venture industry.
What investors should know about “smoothing” of VC returns
Massaging returns during times of volatility is a common practice in private equity, but investors should be aware of the pros and cons.
Hoffman advances at Ørsted
Maria Emilie Danø Hoffman has become the energy company’s director and head of global ventures and open innovation.